All IVF embryos should be checked for genetic defects, conference is told

doi:10.1136/bmj.330.7502.1228

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ research articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Rebecca Coombes

London

All embryos resulting from in vitro fertilisation (IVF) should be routinely checked for genetic abnormalities before implantation, a conference on human genetics heard this week.

New evidence indicates that screening embryos vastly improves the chances of producing a healthy baby in women aged over 35 who undergo IVF.

Dr Yury Verlinsky, a leader in the field of preimplantation genetic diagnosis and director of the Reproductive Genetics Institute, Chicago, told the sixth international symposium on preimplantation genetic diagnosis in London that the findings should lead to only normal embryos being used in treatment.

In a study of 709 couples Dr Verlinsky's team found that the percentage of couples who …